{
 "edition": "20261105-18",
 "language": "zh-Hant",
 "period_start": "2026-11-05T18:00:00+09:00",
 "period_end": "2026-11-05T21:00:00+09:00",
 "page": 4,
 "pages": 4,
 "received_in_period": 315,
 "listed_in_period": 315,
 "description": "這裡一次整合 2 個國家／地區的新聞與公告：台灣 4 個來源 184 條、日本 1 個來源 131 條。每 180 分鐘一期，這期入庫的所有來源、每一條都列出，附原文網址。",
 "countries": [
  {
   "code": "TW",
   "name": "台灣",
   "items": 184,
   "sources": 4
  },
  {
   "code": "JP",
   "name": "日本",
   "items": 131,
   "sources": 1
  }
 ],
 "number_of_items": 15,
 "items": [
  {
   "id": 3749214,
   "anchor": "n3749214",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749214",
   "title": "〈港股盤後〉科網與汽車股全線爆發 恒指強漲約900點 科指飆逾5%",
   "title_state": "source",
   "summary": "港股周四（5日）強勢反彈，恒指漲近900點，科指飆逾5%。科網股如阿里、騰訊、小米大漲，汽車股亦集體走強，惟港股通淨流出213億港元。",
   "summary_state": "source",
   "facts": [
    {
     "text": "恒生指數收盤大漲3.67%或近900點，收報24796.98點。",
     "state": "source",
     "quote": "恒生指數收盤大漲 3.67%或 近900點，收報 24796.98點"
    },
    {
     "text": "恒生科技指數大漲5.55%，收報4154.29點。",
     "state": "source",
     "quote": "恒生科技指數大漲 5.55%，收報 4154.29點"
    },
    {
     "text": "港股通（南向）錄得淨流出213.26億港元。",
     "state": "source",
     "quote": "今日港股通（南向）錄得淨流出 213.26億港元"
    },
    {
     "text": "阿里巴巴-W大漲8.45%，受惠於蘋果國行AI正式落地且Siri深度整合千問模型。",
     "state": "source",
     "quote": "阿里巴巴-W 大漲 8.45%，主要受惠於蘋果國行AI正式落地且Siri深度整合千問模型"
    },
    {
     "text": "騰訊控股因混元最新模型Hy4上線，股價大漲7.17%，全日成交額達241.69億港元。",
     "state": "source",
     "quote": "騰訊控股因混元最新模型Hy4上線，股價大漲 7.17%，全日成交額高居港股榜首，達 241.69億港元"
    },
    {
     "text": "理想汽車-W大漲8.94%，蔚來-SW上漲6.95%。",
     "state": "source",
     "quote": "理想汽車-W 大漲 8.94%，蔚來-SW 上漲 6.95%"
    },
    {
     "text": "布倫特原油單日暴跌跌超10%，拖累中國石油股份回落4.16%。",
     "state": "source",
     "quote": "國際原油單日暴跌（布倫特原油跌超10%）拖累石油股走弱，中國石油股份回落 4.16%"
    }
   ],
   "companies": [
    "恒生指數",
    "恒生科技指數",
    "國企指數",
    "網易",
    "小米集團",
    "阿里巴巴-W",
    "騰訊控股",
    "京東集團",
    "Ceconomy",
    "美團",
    "百度集團",
    "快手",
    "金蝶國際",
    "金山雲",
    "理想汽車-W",
    "蔚來-SW",
    "吉利汽車",
    "零跑汽車",
    "小鵬集團",
    "贛鋒鋰業",
    "寧德時代",
    "中國石油股份"
   ],
   "published_at": "2026-11-05T17:42:05+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6648105",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749215,
   "anchor": "n3749215",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749215",
   "title": "〈陸股盤後〉滬指、創指買盤拉升 三大指數走高",
   "title_state": "source",
   "summary": "中國A股三大指數周四（5日）開低後翻紅走高，滬指、深成指、創指分別收漲0.1%、1.19%、0.87%，成交額增至2.1179兆元。華泰證券與國聯民生分析指出，券商類股估值處低檔具配置價值，科技類股則需關注AI算力及應用現金流品質。",
   "summary_state": "source",
   "facts": [
    {
     "text": "上證綜指周四收盤漲0.1%，報3,689.91點",
     "state": "source",
     "quote": "上證綜指周四收盤漲0.1%，報3,689.91點"
    },
    {
     "text": "兩市成交額為人民幣2.1179兆元，較前一交易日增加802億元",
     "state": "source",
     "quote": "兩市成交額為人民幣2.1179兆元，較前一交易日增加802億元"
    },
    {
     "text": "兩市及北交所共4,868家上漲，623家下跌",
     "state": "source",
     "quote": "兩市及北交所共4,868家上漲，623家下跌，平盤84家"
    },
    {
     "text": "華泰證券建議投資人把握券商類股戰略配置機會",
     "state": "source",
     "quote": "展望2027年，建議投資人把握類股戰略配置機會"
    },
    {
     "text": "國聯民生指出AI算力與商業化落地型應用是科技類股核心變量",
     "state": "source",
     "quote": "AI算力、商業化落地型應用的訂單持續性與現金流品質，可能會成為決定類股上行空間的核心變量"
    }
   ],
   "companies": [
    "Wind",
    "華泰證券",
    "國聯民生"
   ],
   "published_at": "2026-11-05T17:30:03+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647108",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749216,
   "anchor": "n3749216",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749216",
   "title": "美期中選舉引發AI監管疑慮 科技股慘跌拖累日經下跌1.66%",
   "title_state": "source",
   "summary": "日本股市周四因美國期中選舉引發AI監管疑慮，科技股遭拋售導致日經指數下跌1.66%創近3個月新低；相對地東證指數在傳統產業護盤下反彈收高1.2%，兩大指數走勢嚴重脫鉤。",
   "summary_state": "source",
   "facts": [
    {
     "text": "日經指數收盤下跌1.66%或1,030.63點，收在61,158.00點，創下近3個月新低。",
     "state": "source",
     "quote": "代表科技權重較高的日經指數在 AI 及半導體族群重挫拖累下，收盤下跌 1.66%或 1,030.63 點，收在 61,158.00 點，創下近 3 個月新低。"
    },
    {
     "text": "東證指數(TOPIX)反彈收高1.2%，與日經指數漲跌幅差距達2.94個百分點。",
     "state": "source",
     "quote": "涵蓋廣泛產業的東證指數(TOPIX)在傳統產業護盤下反彈收高 1.2%。兩大指數走勢嚴重脫鉤，漲跌幅差距達 2.94 個百分點，創下 2000 年 4 月以來最大紀錄。"
    },
    {
     "text": "日元兌美元回升至157.90附近。",
     "state": "source",
     "quote": "匯市方面，隨美國公債殖利率下滑，日元兌美元回升至 157.90 附近。"
    }
   ],
   "companies": [
    "愛德萬測試",
    "東京威力科創",
    "古河電工",
    "村田製作所",
    "豐田汽車",
    "迅銷",
    "帝人公司",
    "野村證券",
    "東洋證券"
   ],
   "published_at": "2026-11-05T17:20:07+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647980",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749217,
   "anchor": "n3749217",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749217",
   "title": "歷史新高！今年Q3全球DRAM營收飆369% 三星市佔38%穩居首 SK海力士拉開與美光差距",
   "title_state": "source",
   "summary": "今年Q3全球DRAM營收創新高飆升369%，三星以38%市佔居首，SK海力士29%緊追，美光21%排名第三。AI需求使記憶體轉為稀缺資源，供應商業績有望持續刷新。",
   "summary_state": "source",
   "facts": [
    {
     "text": "今年第三季全球DRAM市場營收暴漲369%，創下歷史新高。",
     "state": "source",
     "quote": "今年第三季全球DRAM市場營收暴漲369%，創下歷史新高"
    },
    {
     "text": "三星電子以38%的營收市佔率維持全球第一。",
     "state": "source",
     "quote": "按營收市佔率計算，南韓三星電子以38%維持第一"
    },
    {
     "text": "SK海力士市佔率達29%，拉大與美光科技的差距。",
     "state": "source",
     "quote": "SK海力士市佔率達29%，高過第二季26%有3個百分點，拉大與第三名美光科技(21%)的差距"
    },
    {
     "text": "中國長鑫科技第四名市佔率從10%微降至9%。",
     "state": "source",
     "quote": "第四名中國長鑫科技市佔率則從10%微降至9%"
    },
    {
     "text": "Counterpoint Research預判三星電子有望在明年超越SK海力士拿下HBM市場第一。",
     "state": "source",
     "quote": "Counterpoint Research預判三星電子有望在明年超越SK海力士，拿下市場第一"
    }
   ],
   "companies": [
    "三星電子",
    "SK海力士",
    "美光科技",
    "長鑫科技",
    "Counterpoint Research"
   ],
   "published_at": "2026-11-05T17:20:04+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647979",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749218,
   "anchor": "n3749218",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749218",
   "title": "中鋼12月盤價小漲 穩定供應鏈購料成本擴大接單",
   "title_state": "source",
   "summary": "中鋼(2002-TW)宣布12月盤價每公噸調漲300元，以因應國際鋼價上漲、外銷接單升溫及匯率因素，目的在於穩定供應鏈成本並擴大接單。",
   "summary_state": "source",
   "facts": [
    {
     "text": "中鋼12月盤價決議月盤產品每公噸小幅調漲300元。",
     "state": "source",
     "quote": "決議月盤產品每公噸小幅調漲300元"
    },
    {
     "text": "美國熱軋流通行情突破每公噸1,450美元，創近四年半新高。",
     "state": "source",
     "quote": "美國現貨供應偏緊，熱軋流通行情突破每公噸1,450美元，創近四年半新高"
    },
    {
     "text": "鐵礦砂價格於每公噸90美元附近盤整。",
     "state": "source",
     "quote": "鐵礦砂與冶金煤價格分別於每公噸90美元及265美元附近盤整"
    },
    {
     "text": "中國大陸前三季粗鋼產量年減2.9%。",
     "state": "source",
     "quote": "中國大陸前三季粗鋼產量年減2.9%"
    },
    {
     "text": "日本東京製鐵11月盤價每公噸調漲3,000日圓。",
     "state": "source",
     "quote": "日本東京製鐵11月盤價每公噸調漲3,000日圓（約19美元）"
    }
   ],
   "companies": [
    "中鋼",
    "中鋼(2002-TW)",
    "日本東京製鐵",
    "越南和發鋼廠"
   ],
   "published_at": "2026-11-05T17:10:17+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647973",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749219,
   "anchor": "n3749219",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749219",
   "title": "民主黨大勝美股先崩後拉回、金銀齊揚 市場押注「誰也動不了誰」",
   "title_state": "source",
   "summary": "美國期中選舉民主黨大勝奪回國會兩院，引發全球市場先跌後漲的反轉行情。市場重新定價分權政府帶來的政策僵局，預期其將限制財政擴張，進而利好美債與金銀，科技股則受監管擔憂短期承壓。",
   "summary_state": "source",
   "facts": [
    {
     "text": "民主黨在美國期中選舉中奪回國會參眾兩院，並在德州、南卡羅來納州等共和黨傳統優勢地區勝出。",
     "state": "source",
     "quote": "民主黨不僅拿下眾參兩院，更在德州、南卡羅來納州、堪薩斯州及愛荷華州等共和黨傳統優勢地區勝出"
    },
    {
     "text": "選後那斯達克100指數期貨一度跌逾2%，日經225指數一度跌逾4%，VIX恐慌指數期貨突破20。",
     "state": "source",
     "quote": "那斯達克100指數期貨一度跌逾2%...VIX恐慌指數期貨突破20。亞洲市場同步承壓，日經225指數一度跌逾4%"
    },
    {
     "text": "黃金價格上漲逾2%，重返每盎司4000美元關卡，白銀同步上揚。",
     "state": "source",
     "quote": "金價上漲逾2%，重返每盎司4000美元關卡，白銀同步上揚"
    },
    {
     "text": "5年期美債殖利率一度下跌9個基點至4.68%，10年期下跌7個基點至4.89%。",
     "state": "source",
     "quote": "5年期殖利率一度下跌9個基點至4.68%，10年期下跌7個基點至4.89%"
    },
    {
     "text": "彭博美元現貨指數下跌0.4%，日元兌美元升值0.5%，瑞郎上漲0.7%。",
     "state": "source",
     "quote": "彭博美元現貨指數下跌0.4%，日元兌美元升值0.5%，瑞郎上漲0.7%"
    }
   ],
   "companies": [
    "高盛",
    "Stifel",
    "景順",
    "摩根資產管理",
    "惠靈頓",
    "野村",
    "瑞穗銀行",
    "盛寶",
    "Monex Group",
    "道富環球投資管理",
    "Edward Jones"
   ],
   "published_at": "2026-11-05T17:10:05+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6647627",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749647,
   "anchor": "n3749647",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749647",
   "title": "2026-11-05法人動態：(買超)晟德404張、美時381張、保瑞334張；(賣超)松瑞藥233張、浩鼎221張、漢達217張-環球生技月刊",
   "title_state": "source",
   "summary": "2026年11月5日法人動態，晟德、美時、保瑞為買超前三名；松瑞藥、浩鼎、漢達為賣超前三名。",
   "summary_state": "source",
   "facts": [],
   "companies": [
    "晟德",
    "美時",
    "保瑞",
    "松瑞藥",
    "浩鼎",
    "漢達",
    "東洋",
    "高端疫苗",
    "合一",
    "台耀",
    "神隆",
    "科妍",
    "葡萄王",
    "大江"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91115&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749646,
   "anchor": "n3749646",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749646",
   "title": "2026-11-05生技股：(漲)科妍9.97%、康霈*9.9%、美時5.66%；(跌)漢達9.87%、泰合8.29%、台新藥7.95%-環球生技月刊",
   "title_state": "source",
   "summary": "2026年11月5日生技股行情，科妍漲9.97%居冠，漢達跌9.87%領跌。",
   "summary_state": "source",
   "facts": [],
   "companies": [
    "科妍",
    "康霈*",
    "美時",
    "保瑞",
    "台聯電",
    "視陽",
    "海昌生技",
    "醫影",
    "佰研",
    "馬光-KY",
    "漢達",
    "泰合",
    "台新藥",
    "睿生光電",
    "霈方",
    "泰宗",
    "上亞科技",
    "強生*"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91116&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749645,
   "anchor": "n3749645",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749645",
   "title": "11/05《生技股動態》-環球生技月刊",
   "title_state": "source",
   "summary": "11/05生技股動態涵蓋安基生技、國璽幹細胞等公司之增資與合併案，康霈獲中國NMPA核准一期臨床試驗，並列出當日漲跌及法人買賣超情形。",
   "summary_state": "source",
   "facts": [
    {
     "text": "現增1400萬股",
     "state": "source",
     "quote": "現增1400萬股"
    },
    {
     "text": "每股60元",
     "state": "source",
     "quote": "每股60元"
    },
    {
     "text": "基準日12/6",
     "state": "source",
     "quote": "基準日12/6"
    },
    {
     "text": "暫定合併基準日115/12/31",
     "state": "source",
     "quote": "暫定合併基準日115/12/31"
    },
    {
     "text": "基準日暫定116/1/1",
     "state": "source",
     "quote": "基準日暫定116/1/1"
    },
    {
     "text": "科妍9.97%",
     "state": "source",
     "quote": "科妍9.97%"
    },
    {
     "text": "康霈*9.9%",
     "state": "source",
     "quote": "康霈*9.9%"
    },
    {
     "text": "美時5.66%",
     "state": "source",
     "quote": "美時5.66%"
    },
    {
     "text": "漢達9.87%",
     "state": "source",
     "quote": "漢達9.87%"
    },
    {
     "text": "泰合8.29%",
     "state": "source",
     "quote": "泰合8.29%"
    },
    {
     "text": "台新藥7.95%",
     "state": "source",
     "quote": "台新藥7.95%"
    },
    {
     "text": "晟德404張",
     "state": "source",
     "quote": "晟德404張"
    },
    {
     "text": "美時381張",
     "state": "source",
     "quote": "美時381張"
    },
    {
     "text": "保瑞334張",
     "state": "source",
     "quote": "保瑞334張"
    },
    {
     "text": "松瑞藥233張",
     "state": "source",
     "quote": "松瑞藥233張"
    },
    {
     "text": "浩鼎221張",
     "state": "source",
     "quote": "浩鼎221張"
    },
    {
     "text": "漢達217張",
     "state": "source",
     "quote": "漢達217張"
    }
   ],
   "companies": [
    "安基生技",
    "國璽幹細胞",
    "啟安",
    "敏成健康",
    "躍獅健康",
    "精湛光學",
    "康霈",
    "科妍",
    "美時",
    "漢達",
    "泰合",
    "台新藥",
    "晟德",
    "保瑞",
    "松瑞藥",
    "浩鼎"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91117&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749644,
   "anchor": "n3749644",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749644",
   "title": "精湛光學(2070)115年前三季合併獲利1.06億元，每股稅後2.62元-環球生技月刊",
   "title_state": "source",
   "summary": "精湛光學(2070)公告115年前三季合併財務報告，累計營業收入6.01億元，稅前淨利1.24億元，歸屬於母公司業主淨利1.06億元，基本每股盈餘2.62元。",
   "summary_state": "source",
   "facts": [
    {
     "text": "601,445",
     "state": "source",
     "quote": "601,445"
    },
    {
     "text": "105,611",
     "state": "source",
     "quote": "105,611"
    },
    {
     "text": "124,051",
     "state": "source",
     "quote": "124,051"
    }
   ],
   "companies": [
    "精湛光學",
    "環球生技月刊"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91126&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749643,
   "anchor": "n3749643",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749643",
   "title": "國璽幹細胞(6704)董事會決議與子公司啟安簡易合併，暫定合併基準日115/12/31-環球生技月刊",
   "title_state": "source",
   "summary": "國璽幹細胞應用技術股份有限公司（6704）董事會決議與100%持股子公司啟安國際生醫投資股份有限公司進行簡易合併，暫定合併基準日為115年12月31日，旨在精簡管理費用及成本。",
   "summary_state": "source",
   "facts": [
    {
     "text": "直接持股100%",
     "state": "source",
     "quote": "直接持股100%"
    },
    {
     "text": "事實發生日 115/11/05",
     "state": "source",
     "quote": "事實發生日 115/11/05"
    }
   ],
   "companies": [
    "國璽幹細胞應用技術股份有限公司",
    "國璽公司",
    "啟安國際生醫投資股份有限公司",
    "啟安公司"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91127&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749642,
   "anchor": "n3749642",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749642",
   "title": "國璽幹細胞(6704)董事會決議與子公司啟安簡易合併，債權人異議期11/6~12/30-環球生技月刊",
   "title_state": "source",
   "summary": "國璽幹細胞(6704)子公司啟安國際生醫投資股份有限公司經董事會決議與母公司進行簡易合併，暫訂合併基準日為115年12月31日，債權人異議期為115年11月6日至12月30日。",
   "summary_state": "source",
   "facts": [
    {
     "text": "100%持有",
     "state": "source",
     "quote": "100%持有"
    },
    {
     "text": "民國(下同)115年11月05日",
     "state": "source",
     "quote": "民國(下同)115年11月05日"
    },
    {
     "text": "暫訂合併基準日為115年12月31日",
     "state": "source",
     "quote": "暫訂合併基準日為115年12月31日"
    },
    {
     "text": "115年11月06日至115年12月30日期間內",
     "state": "source",
     "quote": "115年11月06日至115年12月30日期間內"
    }
   ],
   "companies": [
    "國璽幹細胞應用技術股份有限公司",
    "啟安國際生醫投資股份有限公司"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91128&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749641,
   "anchor": "n3749641",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749641",
   "title": "國璽幹細胞(6704)：子公司啟安與母公司簡易合併，暫定合併基準日115/12/31-環球生技月刊",
   "title_state": "source",
   "summary": "國璽幹細胞(6704)公告子公司啟安國際生醫投資股份有限公司與母公司進行簡易合併，暫定合併基準日為115/12/31，旨在精簡管理費用及成本。",
   "summary_state": "source",
   "facts": [
    {
     "text": "直接持股100%",
     "state": "source",
     "quote": "直接持股100%"
    },
    {
     "text": "事實發生日 115/11/05",
     "state": "source",
     "quote": "事實發生日 115/11/05"
    }
   ],
   "companies": [
    "國璽幹細胞應用技術股份有限公司",
    "國璽公司",
    "啟安國際生醫投資股份有限公司",
    "啟安公司",
    "國璽幹細胞"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91129&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749640,
   "anchor": "n3749640",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749640",
   "title": "安基生技(7754)現增1400萬股案，每股60元，基準日12/6-環球生技月刊",
   "title_state": "source",
   "summary": "安基生技(7754)公告現金增資1,400萬股，每股發行價格60元，認股基準日訂為115年12月6日，資金用途為充實營運資金。",
   "summary_state": "source",
   "facts": [
    {
     "text": "14,000,000股",
     "state": "source",
     "quote": "14,000,000股"
    },
    {
     "text": "每股新台幣60元整",
     "state": "source",
     "quote": "每股新台幣60元整"
    },
    {
     "text": "140,000,000元整",
     "state": "source",
     "quote": "140,000,000元整"
    },
    {
     "text": "1,400,000股",
     "state": "source",
     "quote": "1,400,000股"
    },
    {
     "text": "12,600,000股",
     "state": "source",
     "quote": "12,600,000股"
    }
   ],
   "companies": [
    "安基生技"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91130&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3749630,
   "anchor": "n3749630",
   "permalink": "https://ainews.idaeo.ai/180m/20261105-18/index-zh-Hant-p4.html#n3749630",
   "title": "安基生技(7754)現增1400萬股案，每股60元，基準日12/6-環球生技月刊",
   "title_state": "source",
   "summary": "安基生技(7754)公告現金增資案，發行1,400萬股，每股認購價60元，基準日訂為115年12月6日，資金用途為充實營運資金。",
   "summary_state": "source",
   "facts": [
    {
     "text": "14,000,000股",
     "state": "source",
     "quote": "14,000,000股"
    },
    {
     "text": "每股新台幣60元整",
     "state": "source",
     "quote": "每股新台幣60元整"
    },
    {
     "text": "140,000,000元整",
     "state": "source",
     "quote": "140,000,000元整"
    },
    {
     "text": "1,400,000股",
     "state": "source",
     "quote": "1,400,000股"
    },
    {
     "text": "12,600,000股",
     "state": "source",
     "quote": "12,600,000股"
    }
   ],
   "companies": [
    "安基生技"
   ],
   "published_at": "2026-11-05T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=91130&range=news",
   "link_level": "source",
   "link_label": "原文",
   "site_url": null,
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  }
 ]
}